Skip to main content
Transcenta Holding Limited logo

Transcenta Holding Limited — Investor Relations & Filings

Ticker · 6628 ISIN · KYG9005B1041 HKEX Manufacturing
Filings indexed 482 across all filing types
Latest filing 2024-05-07 Regulatory Filings
Country HK Hong Kong
Listing HKEX 6628

About Transcenta Holding Limited

http://www.transcenta.com

Transcenta Holding Limited is a clinical-stage global biotherapeutics company specializing in the discovery, research, development, and manufacturing of differentiated antibody-based therapeutics. The company operates a fully integrated platform, utilizing a unique antibody generation platform based on Immune Tolerance Breaking Technology to generate candidate leads. Its robust pipeline includes therapeutic antibody molecules targeting oncology and selected non-oncology indications, such as bone and kidney disorders. The company employs advanced bioprocessing technologies, including perfusion-based continuous bioprocessing, to accelerate process development and reduce manufacturing costs.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024 (Updated)
Regulatory Filings Classification · 100% confidence The document is titled 'Monthly Return for Equity Issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules on Movements in Securities' for the month ended 30 April 2024. It details movements in authorized and issued shares, share options, repurchases, and confirmations related to securities issued by the company. The content focuses on share capital changes, share options, repurchases, and compliance confirmations. There are no financial statements, earnings data, or management discussion of financial results. The document is a regulatory return related to share capital movements and securities, submitted to the Hong Kong Exchanges and Clearing Limited. This type of filing corresponds to a Regulatory Filing (RNS) as it is a compliance report on share capital movements and confirmations rather than a financial report or announcement of voting results or capital raising.
2024-05-07 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Transcenta Holding Limited. It includes detailed tables of repurchases of shares on various dates, confirmations of compliance with listing rules, and purchase reports. The content focuses on share repurchase activities and disclosures required by the Stock Exchange of Hong Kong. There are no financial statements, earnings data, management discussion, or other report types present. The document is a regulatory disclosure about share repurchases, fitting the definition of a Transaction in Own Shares (POS) filing, which covers company buybacks or sales of its own shares.
2024-05-07 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024
Transaction in Own Shares Classification · 95% confidence The document is titled 'Monthly Return for Equity Issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules on Movements in Securities' for the month ended 30 April 2024. It details movements in authorized and issued share capital, share options, repurchases of shares, and confirmations related to securities issued. The document is a regulatory submission to the Hong Kong Exchanges and Clearing Limited, reporting share capital changes and share repurchase activities for the month. It does not contain financial statements, earnings data, or management discussion. It is a regulatory compliance filing focused on share capital movements and share repurchases. This fits the category of Transaction in Own Shares (POS), which covers reports of the company buying back or selling its own shares. The document length is substantial and contains detailed tables of share movements and repurchases, confirming it is the report itself, not just an announcement. Therefore, the correct classification is POS with high confidence.
2024-05-07 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Transcenta Holding Limited. It includes detailed data on repurchases of shares, dates, quantities, prices, and confirmations of compliance with listing rules on the Stock Exchange of Hong Kong. The document is a regulatory disclosure about share repurchases and changes in capital, not a full financial report or earnings release. It is a formal regulatory filing required by the exchange to disclose share buybacks and capital changes. Therefore, it fits best under the category of Transaction in Own Shares (POS), which covers reports of the company buying back or selling its own shares.
2024-05-06 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Transcenta Holding Limited. It details repurchases of shares on various dates, including quantities and prices, and confirms compliance with listing rules. The document is a regulatory disclosure about share repurchases and capital changes, not a full financial report or earnings release. It is not an announcement of a report publication but a formal regulatory filing required by the stock exchange. Therefore, it fits best under 'Transaction in Own Shares' (POS) category, which covers reports of the company buying back or selling its own shares.
2024-05-03 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Transcenta Holding Limited. It details repurchases of shares on various dates, including quantities and prices, and confirms compliance with listing rules. The document is a regulatory disclosure about share repurchases, not a full financial report or earnings release. It fits the description of a 'Transaction in Own Shares' filing, which reports company buybacks or sales of its own shares. The document length is over 11,000 characters and contains detailed transactional data, confirming it is not a brief announcement or certification. Therefore, the appropriate classification is POS (Transaction in Own Shares).
2024-05-02 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.